Literature DB >> 19555582

NCCN clinical practice guidelines in oncology: testicular cancer.

Robert J Motzer1, Neeraj Agarwal, Clair Beard, Graeme B Bolger, Barry Boston, Michael A Carducci, Toni K Choueiri, Robert A Figlin, Mayer Fishman, Steven L Hancock, Gary R Hudes, Eric Jonasch, Anne Kessinger, Timothy M Kuzel, Paul H Lange, Ellis G Levine, Kim A Margolin, M Dror Michaelson, Thomas Olencki, Roberto Pili, Bruce G Redman, Cary N Robertson, Lawrence H Schwartz, Joel Sheinfeld, Jue Wang.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19555582     DOI： 10.6004/jnccn.2009.0047

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  38 in total

Review 1.  Testicular cancer: when less is more.

Authors:  Lance C Pagliaro
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

2.  Long-term health effects among testicular cancer survivors.

Authors:  Mia Hashibe; Sarah Abdelaziz; Mohammed Al-Temimi; Alison Fraser; Kenneth M Boucher; Ken Smith; Yuan-Chin Amy Lee; Kerry Rowe; Braden Rowley; Micky Daurelle; Avery E Holton; James VanDerslice; Lorenzo Richiardi; Jay Bishoff; Will Lowrance; Antoinette Stroup
Journal:  J Cancer Surviv       Date:  2016-05-11       Impact factor: 4.442

3.  Management of testicular cancer: NYU case of the month, March 2017.

Authors:  James S Wysock
Journal:  Rev Urol       Date:  2017

4.  Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Authors:  Chunkit Fung; Howard D Sesso; Annalynn M Williams; Sarah L Kerns; Patrick Monahan; Mohammad Abu Zaid; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair J Beard; Christian K Kollmannsberger; Ryan Cook; Sandra Althouse; Shirin Ardeshir-Rouhani-Fard; Steve E Lipshultz; Lawrence H Einhorn; Sophie D Fossa; Lois B Travis
Journal:  J Clin Oncol       Date:  2017-02-27       Impact factor: 44.544

Review 5.  Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature.

Authors:  Mehmet Asim Bilen; Houssam Hariri; Chady Leon; Charles C Guo; Deborah A Kuban; Louis L Pisters; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2014-02-28       Impact factor: 2.872

Review 6.  Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer.

Authors:  Harsha R Mittakanti; James R Porter
Journal:  Transl Androl Urol       Date:  2020-01

7.  Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.

Authors:  Jonathan L Silberstein; Stephen A Poon; Daniel D Sjoberg; Alexandra C Maschino; Andrew J Vickers; Aaron Bernie; Badrinath R Konety; W Kevin Kelly; James A Eastham
Journal:  BJU Int       Date:  2015-04-17       Impact factor: 5.588

8.  Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox.

Authors:  Pari V Pandharipande; Jonathan D Eisenberg; Richard J Lee; Michael E Gilmore; Ekin A Turan; Sarabjeet Singh; Mannudeep K Kalra; Bob Liu; Chung Yin Kong; G Scott Gazelle
Journal:  Radiology       Date:  2012-12-18       Impact factor: 11.105

9.  Update on management of seminoma.

Authors:  Emma J Alexander; Ingrid M White; Alan Horwich
Journal:  Indian J Urol       Date:  2010 Jan-Mar

10.  Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors.

Authors:  Pei Dong; Zhuo-Wei Liu; Xiang-Dong Li; Yong-Hong Li; Kai Yao; Song Wu; Zi-Ke Qin; Hui Han; Fang-Jian Zhou
Journal:  Med Oncol       Date:  2013-02-12       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.